Early versus delayed endocrine treatment of pN1-3 MO prostate cancer without local treatment of the primary tumor: Results of European organisation for the research and treatment of cancer 30846 - A phase III study

2004-09-01

Early versus delayed endocrine treatment of pN1-3 MO prostate cancer without local treatment of the primary tumor

Results of European organisation for the research and treatment of cancer 30846 - A phase III study

The Journal of Urology , Volume 172 - Issue 3 p. 923- 927

Additional Metadata
Keywords	Androgen antagonists, Lymph nodes, Neoplasm metastasis, Prostate, Prostatic neoplasms
Persistent URL	doi.org/10.1097/01.ju.0000135742.13171.d2, hdl.handle.net/1765/62091
Journal	The Journal of Urology
Organisation	Department of Urology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Schröder, F., Kurth, K., Fossa, S., Hoekstra, W., Karthaus, P., Debois, M., & Collette, L. (2004). Early versus delayed endocrine treatment of pN1-3 MO prostate cancer without local treatment of the primary tumor: Results of European organisation for the research and treatment of cancer 30846 - A phase III study. The Journal of Urology, 172(3), 923–927. doi:10.1097/01.ju.0000135742.13171.d2